Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-MB 231 human breast cancer cells

In Vivo

Volumn 21, Issue 2, 2007, Pages 349-355

  Hostanska, Katarina ^a   Nisslein, Thomas ^b   Freudenstein, Johannes ^b   Reichling, Juergen ^c   Saller, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Schaper & Brummer GmbH & Co KG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Black cohosh; Invasion; MDA MB 231 breast cancer cells

Indexed keywords

2 PROPANOL; ANTINEOPLASTIC AGENT; CIMICIFUGA RACEMOSA EXTRACT; CINNAMIC ACID ESTER; MATRIGEL; TRITERPENIC GLYCOSIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL VIABILITY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PLANT ROOT;

EID: 34047214284     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Liotta LA and Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106, 1990.
2. Benelli R, Vene R, Bisacchi D, Garbisa S and Albini A: Antiinvasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 383: 101-105, 2002.
3. Latruffe N, Delmas D, Jannin B, Malki MC, Passilly-Degrace P and Berlot J-P: Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med 10: 755-760, 2002.
4. Lindenmeyer F, Li H, Menashi S, Soria C and Lu H: Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr Cancer 39: 139-147, 2001.
5. Lieberman S: A review of the effectiveness of Cimicifuga racemosa (Black Cohosh) for the symptoms of menopause. J Women's Health 7: 525-529, 1998.
6. Borrelli F, Izzo AA and Ernst E: Pharmacological effects of Cimicifuga racemosa. Life Sci 73: 1215-1229, 2003.
7. Bodinet C and Freudenstein J: Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat 76: 1-10, 2002.
8. Hostanska K, Nisslein T, Freudenstein J, Reichling J and Saller R: Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat 84: 151-160, 2004.
9. Einbond LS, Shimizu M, Xiao D, Nuntanakorn P, Lim JTE, Suzui M, Seter C, Pertel T, Kennelly EJ, Kronenberg F and Weinstein IB: Growth inhibitory activity of extract and purified components of black cohosh on human breast cancer cells. Breast Cancer Res Treat 83: 221-231, 2004.
10. Hostanska K, Nisslein T, Freudenstein J, Reichling J and Saller R: Apoptosis of human prostate androgen-dependent and-independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Anticancer Res 25: 139-148, 2005.
11. Jarry H, Thelen P, Christoffel V, Spengler B and Wuttke W: Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP. Phytomedicine 12: 178-182, 2005
12. Kapadia GJ, Azuine MA, Tokuda H, Hang E, Mukainaka T, Nishino H and Sridhar R: Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation. Pharmacol Res 45: 213-220, 2002.
13. Seidlova-Wuttke D, Thelen P and Wuttke W: Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer. Planta Med 72: 521-526, 2006.
14. Hostanska K, Nisslein T, Freudenstein J, Reichling J and Saller R: Evaluation of cell death by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull 27: 1970-1975, 2004.
15. Shao Y, Harris A, Wang M, Zhang H, Cordell AG, Bowman M and Lemmo E: Triterpene glycosides from Cimicifuga racemosa. J Nat Prod 63: 905-910, 2000.
16. Sakurai N, Wu JH, Sachida Y, Mimaki Y, Nikaido T, Koike K, Itikawa H and Lee KH: Anti-AIDS agent. Part 57: Actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins. Bioorg Med Chem 14: 1329-1332, 2004.
17. Stromeier S, Petereit F and Nahrstedt A: Phenolic esters from rhizomes of Cimicifuga racemosa do not cause proliferation effect in MCF-7 cells. Planta Med 71: 495-500, 2005.
18. Nuntakanakorn P, Jiang B, Einbond LS, Yang H, Kronenberg F, Weinstein IB and Kennelly EJ: Polyphenolic constituents of Actaea racemosa. J Nat Prod 69: 314-318, 2006.
19. Welch DR, Lobl TJ, Seftor EA, Wack PJ, Aeed PA, Yohem KH, Seftor REB and Hendrix MCJ: Use of the membrane invasion culture system (MICS) as a screen for anti-invasive agents. Int J Cancer 43: 449-457, 1989.
20. Henderson IC and Patek AJ: The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 52: 261-288, 1998.
21. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, de Witte P, Merlevede W and Baraldi M: Effects of Hypericum perforatum extract in locomotoric and anxiolytic animal tests. Pharmacol Biochem Behav 64: 627-633, 2000.
22. Lupu R, Mehmi L, Atlas E, Tsai MS, Pisha E, Oketch-Rabah HA, Nuntanakorn P, Kennelly EJ and Kroneberg F: Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Onvol 23: 1407-1412, 2003.
23. Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S and Garcia M: Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 65: 163-168, 1998.
24. Belotti D, Rieppi M, Nicoletti MI, Casazza AM, Fojo T, Taraboletti G and Giavazzi R: Paclitaxel (Taxol®) inhibits motility of paclitaxel-resistent human ovarian carcinoma cells. Clin Cancer Res 2: 1725-1730, 1996.
25. Westerlund A, Hujanen E, Höyhtyä M, Puistola U and Turpeenniemi-Hujanen T: Ovarian cancer cell invasion is inhibited by paclitaxel. Clin Exp Metastasis 15: 318-328, 1997.
26. Lokeshwar BL, Escatel E and Zhu B: Cytotoxic activity and inhibition of tumor cell invasion by derivates of a chemically modified tetracycline CMT-3 (COL-3). Current Med Chem 8: 271-279, 2001.
27. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I and Schmitt FC: Cyclooxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55: 429-434, 2002.
28. Larkins TL, Nowell M, Singh S and Sanford GL: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6: 181-192, 2006.
29. Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T and Nagasue N: Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med 143: 207-216, 2004.
30. Kretzschmar G, Nisslein T, Zierau O and Vollmer G: No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment. J Steroid Biochem Mol Biol 97: 271-277, 2005.
31. Hernandez Munoz G and Pluchino S: Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 44 Suppl 1: 59-65, 2003.